Navigation Links
57 college presidents declare support for public access to publicly funded research in the US
Date:9/23/2009

on the Internet. In addition, it leaves control of the final published version of articles, which is generally used for citation purposes, in the hands of publishers.

Adoption of the Federal Research Public Access Act will democratize access to research information funded by tax dollars. It will benefit education, research, and the general public. We urge the higher education community, American taxpayers, and members of Congress to support its passage into law.

[end letter text]

The letter, available at http://www.oberlingroup.org/open-letter-federal-research-public-access-act, was organized through the library directors of the Oberlin Group, a consortium of 80 liberal arts college libraries nationwide.

The Federal Research Public Access Act proposes to build upon the success of the first U.S. requirement for public access to publicly funded research (through the National Institutes of Health Public Access Policy) and is supported by: 90 research, advocacy, publishing, and student organizations that represent the Alliance for Taxpayer Access; the Academic Council of the University of California System; NetCoalition.com (representing Amazon.com, Ask.com, Bloomberg, eBay, Google, Yahoo!, and Wikipedia, as well as state and local ISPs); the Rockefeller University Press; OXFAM; and major national and regional research organizations. For details, visit http://www.taxpayeraccess.org/frpaa.


'/>"/>

Contact: Jennifer McLennan
jennifer@arl.org
202-296-2296
SPARC
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Kings College London signs agreement to strengthen Brazilian research links
2. American College of Preventive Medicine releases lifestyle medicine literature review
3. 22nd Congress of the European College of Neuropsychopharmacology, Sept. 12-16, 2009, Turkey
4. Enzyme involved in inflammatory bowel disease discovered at Penn State College of Medicine
5. 22nd Congress of the European College of Neuropsychopharmacology
6. American College of Medical Genetics affirms importance of newborn screening dried blood spots
7. Genetic secrets of date palm unlocked by researchers at Weill Cornell Medical College in Qatar
8. Boston College chemistry professor Udayan Mohanty receives a 2009 Guggenheim Fellowship
9. Imperial College London and NTU collaborate to offer joint Ph.D. programs in engineering and science
10. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
11. NYU College of Dentistry awarded $1.9 million NIH grant for HIV research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... of Energy Steven Chu announced today the winners of ... in research and development supporting the Department of Energy ... will receive a gold medal, a citation and $50,000. ... in Washington, DC early next year., "The contributions made ... energy security of the United States are wide-ranging and ...
(Date:12/16/2009)... that short-term, seasonal exposure to pesticides in rivers ... of wild salmon populations. In addition to the ... that exposure to commonly used pesticides may further ... , "Major efforts are currently underway to ... recover depressed populations," says David Baldwin of the ...
(Date:12/16/2009)... 1 GestureTek Inc. today announced ... - a turnkey, portable, plug and play ... entertainment and touring promotions. GestureTek is the ... in camera-enabled gesture recognition technology for interactive ... for quality, the CUBE has TUV, CE, ...
Breaking Biology News(10 mins):Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 1Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 2Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 3Hispanic children in US at greater risk for obesity than other ethnic racial groups 47469 1Hispanic children in US at greater risk for obesity than other ethnic racial groups 47469 2Is your environment damaging your health 3F New center aims to find out 47466 1Is your environment damaging your health 3F New center aims to find out 47466 2Is your environment damaging your health 3F New center aims to find out 47466 3
... Spearhead Effort in Support of "New Employee,Verification Act", ... largest,association devoted to human resource management today led ... endorse the "New Employee,Verification Act." In testimony today ... Security, Sue Meisinger, President and CEO of SHRM,urged ...
... A better understanding of brain injury, a way to ... to monitor their glaucoma at home, number among this ... day. , What surprises me every time I walk ... projects involving so many NJIT graduate and undergraduate students, ...
... . , A new brain-imaging study by researchers ... - a stomach hormone, acts on specific regions of the ... eating for pleasure. This study, published in the May ... and treating obesity, a condition affecting millions world-wide. , Appetite ...
Other Biology News:SHRM CEO Testifies Before House Subcommittee on Social Security 2SHRM CEO Testifies Before House Subcommittee on Social Security 3NJIT applauds students for studies on brain injury, glaucoma and more 2Hunger hormone: Makes food more attractive 2
(Date:12/16/2009)... Special Protocol Assessment with the Food and ... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... global biopharmaceutical company focused on oncology and ... its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( ... trial for perifosine (KRX-0401), the Company,s PI3K/Akt ...
(Date:12/16/2009)... Peptone. HSP A has been found to be effectinve in ... ... 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting ... HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high ... and yields. HSP-A has been found to be especially effective ...
(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...
(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... - Market Forecasts to 2015, Pipeline Analysis ... http://www.reportlinker.com/p0168104/The-Future-of-Orphan-Diseases-Therapeutics---Market-Forecasts-to-2015-Pipeline-Analysis-and-Reimbursement.html ,, Summary ... latest research "The Future of Orphan Diseases ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18
... Mezzanine Debt Facility; Support Profitable GrowthALISO VIEJO, Calif., May ... CLRT ), a premier anatomic pathology and ... pharmaceutical industry, announced today that it has completed the ... stock with Oak Investment Partners , ...
... The Institut Pasteur and Merieux Alliance,have signed a letter ... The Institut Pasteur and Merieux Alliance ... Silliker) would like to,pool their resources and efforts to ... fields: , , - Clinical diagnostics ...
... With Movement Disorders at Home and in a Variety ... people in the US have diseases or conditions that ... traditional walking aids such as canes and walkers are ... and live independently.Now there,s a high-tech yet easy-to-use gait-training ...
Other Biology Technology:Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 2Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 3Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 4Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 5Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 6The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases 2The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases 3Now Available: State-of-the-Art Gait Training Device to Help Millions Walk More Normally Again 2
Human DEP-1/CD148 Fluorescein MAb (Clone 143-41) Protein Family: Granulocyte Markers, Monocyte Markers, Phosphatases & Regulators, Other Dendritic Cell Molecules...
MOUSE ANTI PORCINE SLA 1:FITC Immunogen: Porcine peripheral blood mononuclear cells....
NNT-1/BSF-3 (N-14)...
Monoclonal 8C2.1 is specific for Bunyavirus G1 as tested by neutralization, immunoprecipitation and immunobinding assays....
Biology Products: